Literature DB >> 22109110

Impact of depression on quality of life in people living with human T cell lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil.

Ana Verena Galvão-Castro1, Ney Boa-Sorte, Ramon Almeida Kruschewsky, Maria Fernanda Rios Grassi, Bernardo Galvão-Castro.   

Abstract

PURPOSE: A previous study found the prevalence of depression in HTLV-1-infected patients to be approximately 30%, but few studies have attempted to correlate depression with quality of life (QOL) in these patients. The present study investigates the association between depression and QOL in people living with HTLV-1.
METHODS: A clinical-epidemiological questionnaire, the Mini International Neuropsychiatric Interview and the WHOQOL-Bref were applied to 88 HTLV-1-infected patients (32 with TSP/HAM) at the HTLV Center of the Bahiana School of Medicine and Public Health, Salvador, Brazil.
RESULTS: The prevalence of depression among people living with HTLV-1 was 34.1%. Depression was significantly associated with a poor QOL in the physical, psychological, social relationship and environment domains, when controlling for other variables, such as gender, age, time of knowledge of serological diagnosis and presence of tropical spastic paraparesis/HTLV-1associated myelopathy (TSP/HAM). Moreover, patients with TSP/HAM experienced a reduction in their QOL in the physical, psychological and environment domains.
CONCLUSION: Our results showed that depression negatively affects the quality of life of people living with HTLV-1, regardless of the presence of TSP/HAM. Since it is possible to improve a patient's QOL by treating depression, psychological evaluations are strongly recommended as a measure to integrate the treatment protocols of HTLV-1 intervention programs.

Entities:  

Mesh:

Year:  2011        PMID: 22109110     DOI: 10.1007/s11136-011-0066-6

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  33 in total

1.  Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM).

Authors:  Carlos M De Castro-Costa; Abelardo Q C Araújo; Márcio M Barreto; Osvaldo M Takayanagui; Marzia P Sohler; Eduardo L M da Silva; Sônia M B de Paula; Ricardo Ishak; João G R Ribas; Luis C Rovirosa; Herwig Carton; Eduardo Gotuzzo; William W Hall; Silvia Montano; Edward L Murphy; Joel Oger; Carlos Remondegui; Graham P Taylor
Journal:  AIDS Res Hum Retroviruses       Date:  2006-10       Impact factor: 2.205

Review 2.  Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.

Authors:  Heath D Schmidt; Richard C Shelton; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

3.  Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group.

Authors: 
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

4.  Implications of HAM/TSP functional incapacity in the quality of life.

Authors:  Marcia Shublaq; Marco Orsini; Marzia Puccioni-Sohler
Journal:  Arq Neuropsiquiatr       Date:  2011-04       Impact factor: 1.420

5.  Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study.

Authors:  B Galvão-Castro; L Loures; L G Rodriques; A Sereno; O C Ferreira Júnior; L G Franco; M Muller; D A Sampaio; A Santana; L M Passos; F Proietti
Journal:  Transfusion       Date:  1997-02       Impact factor: 3.157

6.  Spread and diversity of human populations in Bahia, Brazil.

Authors:  E S Azevêdo; C M Fortuna; K M Silva; M G Sousa; M A Machado; A M Lima; M E Aguiar; K Abé; M C Eulálio; M M Conceição; M C Silva; M G Santos
Journal:  Hum Biol       Date:  1982-05       Impact factor: 0.553

7.  [Comorbidity of chronic diseases and psychiatric disorders among patients attending public primary care].

Authors:  C Fullerton; R Florenzano; J Acuña
Journal:  Rev Med Chil       Date:  2000-07       Impact factor: 0.553

Review 8.  Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression.

Authors:  Charles L Raison; Christopher A Lowry; Graham A W Rook
Journal:  Arch Gen Psychiatry       Date:  2010-12

9.  Frequency of mental disturbances in HTLV-1 patients in the state of Bahia, Brazil.

Authors:  André Gordilho Joaquim de Carvalho; Ana Verena Galvão-Phileto; Nana Santos Lima; Rogério Santos de Jesus; Bernardo Galvão-Castro; Manuela Garcia Lima
Journal:  Braz J Infect Dis       Date:  2009-02       Impact factor: 1.949

Review 10.  An HTLV-I vaccine: why, how, for whom?

Authors:  G de Thé; R Bomford
Journal:  AIDS Res Hum Retroviruses       Date:  1993-05       Impact factor: 2.205

View more
  9 in total

1.  Oral health and quality of life of people living with human T-cell leukemia virus-1 in Salvador, Brazil: a cross-sectional study.

Authors:  Gleicy Gabriela Vitória Spínola Carneiro Falcão; Viviane Almeida Sarmento; Brenda Soares Dutra; Bruno Russoni; Letycia Santos de Oliveira; Dayana Alves Costa; Carlos Brites; Jerry E Bouqout; Liliane Lins-Kusterer
Journal:  Clin Oral Investig       Date:  2021-10-19       Impact factor: 3.573

2.  Integrative and Multidisciplinary Care for People Living With Human T-Cell Lymphotropic Virus in Bahia, Brazil: 20 Years of Experience.

Authors:  Bernardo Galvão-Castro; Maria Fernanda Rios Grassi; Ana Verena Galvão-Castro; Aidê Nunes; Ana Karina Galvão-Barroso; Thessika Hialla Almeida Araújo; Regina Helena Rathsam-Pinheiro; Ceuci Lima Xavier Nunes; Adriele Ribeiro; Monique Lírio; Noilson Lázaro Gonçalves; Sônia Lúcia Rangel; Cristiane Maria Carvalho Costa Dias; Daniele Piai Ozores; Selena Márcia Dubois-Mendes; Isabela Lima; André Luís Pereira Silva; Washington Luiz Abreu de Jesus; Fred Luciano Neves Santos; José Guilherme Reis de Oliveira; Yscela Vanessa Pimentel de Moraes; Adijeane Oliveira de Jesus; Francisco Daltro; Ney Boa-Sorte; Humberto Castro-Lima; Maria Luísa Carvalho Soliani
Journal:  Front Med (Lausanne)       Date:  2022-06-07

3.  Psychiatric Disorders in HTLV-1-Infected Individuals with Bladder Symptoms.

Authors:  Glória O Orge; Thais R Dellavechia; José Abraão Carneiro-Neto; Lucas Araújo-de-Freitas; Carla H C Daltro; Carlos T Santos; Lucas C Quarantini
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

4.  Estimation of HTLV-1 vertical transmission cases in Brazil per annum.

Authors:  Carolina Rosadas; Bassit Malik; Graham P Taylor; Marzia Puccioni-Sohler
Journal:  PLoS Negl Trop Dis       Date:  2018-11-12

5.  Health state utility values in people living with HTLV-1 and in patients with HAM/TSP: The impact of a neglected disease on the quality of life.

Authors:  Carolina Rosadas; Tatiane Assone; Marina Yamashita; Adine Adonis; Marzia Puccioni-Sohler; Marisa Santos; Arthur Paiva; Jorge Casseb; Augusto C P Oliveira; Graham P Taylor
Journal:  PLoS Negl Trop Dis       Date:  2020-10-16

6.  Comparison of functioning and health-related quality of life among patients with HTLV-1, HIV, and HIV-HTLV-1-coinfection.

Authors:  Cleyde Sheyla Chachaqui Marconi; Liliane Lins-Kusterer; Carlos Brites; Mansueto Gomes-Neto
Journal:  Rev Soc Bras Med Trop       Date:  2021-03-22       Impact factor: 1.581

Review 7.  Blocking HTLV-1/2 silent transmission in Brazil: Current public health policies and proposal for additional strategies.

Authors:  Carolina Rosadas; Maria Luiza B Menezes; Bernardo Galvão-Castro; Tatiane Assone; Angélica E Miranda; Mayra G Aragón; Adele Caterino-de-Araujo; Graham P Taylor; Ricardo Ishak
Journal:  PLoS Negl Trop Dis       Date:  2021-09-23

8.  HAM/TSP and major depression: the role of age.

Authors:  Ney Boa-Sorte; Ana Verena Galvão-Castro; Danilo Borba; Renan Barbalho Nunes de Castro Lima; Bernardo Galvão-Castro
Journal:  Braz J Infect Dis       Date:  2015-01-27       Impact factor: 3.257

9.  Quality of life, risk behaviors and depression among carriers of hepatitis C virus and human T-cell lymphotropic virus type 1: a comparative study.

Authors:  Ricardo Henrique-Araújo; Lucas C Quarantini; André C Caribé; Felipe C Argolo; Ana Paula Jesus-Nunes; Mychelle Morais-de-Jesus; Adriana Dantas-Duarte; Tayne Miranda Moreira; Irismar Reis de Oliveira
Journal:  Braz J Infect Dis       Date:  2019-07-22       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.